New Delhi, February 24
The National Pharmaceutical Pricing Authority (NPPA) has received complaints against two hospitals in Uttarakhand and Haryana for overcharging for stents.
In a tweet, the NPPA today said its helpline had received complaint against Bharat Heart Institute, Dehradun, and Oxygen Hospital, Rohtak, for overcharging.
In another tweet, the drug price regulator said the “cap of the 8 per cent margin in trade channel of coronary stents is meant to stop unethical marketing practices which lead to poor quality of stents”.
Yesterday, the NPPA had said it had issued show-cause notices to some hospitals for overpricing for stents.
In a major relief to patients, the NPPA last week slashed the prices of coronary stents by up to 85 per cent, capping these at Rs 7,260 for bare metal ones and Rs 29,600 for the drug eluting variety. — PTI
Most Read In 24 Hours
Don't Miss
View All
Top News
US sanctions Chinese suppliers for providing critical components of Pakistan’s ballistic missile programme
As a result of the action, all property and interests in pro...
Iraq's popular mobilization forces post hit in air strike, sources say
US official said there had been no US military activity in I...
Indian student's death in US possibly linked to 'Blue Whale Challenge': Report
The 20-year-old, who will remain unnamed here in deference t...
Punjab leader Tajinder Bittu resigns from Congress; BJP’s spokesperson Jaiveer Shergill wishes him luck for ‘new innings’
He was AICC secretary and co-charge of Himachal Pradesh
Tesla's Elon Musk postpones India trip, sources say
Tesla and Modi's office did not immediately respond to reque...
